Suppr超能文献

协调重症联合免疫缺陷病新生儿筛查中的TREC阈值:来自俄罗斯验证队列的见解

Harmonizing TREC Thresholds in Newborn Screening for SCID: Insights From Russian Validation Cohort.

作者信息

Marakhonov Andrey, Kalinina Ekaterina, Larin Sergey, Khadzhieva Maryam, Dudina Ekaterina, Mukhina Anna, Rodina Yulia, Efimova Irina, Balinova Natalya, Sermyagina Irina, Shchagina Olga, Zinchenko Rena, Voronin Sergey, Shcherbina Anna, Kutsev Sergey

机构信息

Research Centre for Medical Genetics, Moscow, Russia.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.

出版信息

J Clin Lab Anal. 2025 Aug;39(16):e70078. doi: 10.1002/jcla.70078. Epub 2025 Jul 12.

Abstract

BACKGROUND

Newborn screening (NBS) for severe combined immunodeficiency (SCID) relies on the measurement of T-cell receptor excision circle (TREC) for early diagnosis and intervention. However, considerable variation in TREC cutoff values across countries and testing platforms poses challenges for standardization and optimal screening performance. This study aimed to refine the TREC cutoff values in a large Russian pilot NBS cohort comprising 202,908 newborns, with a primary focus on improving SCID detection sensitivity.

METHODS

A retrospective analysis of 202,908 newborns from a pilot NBS project assessed TREC and KREC levels. Confirmed PID diagnoses were compared with TREC measurements in a group of 66 false-positive cases. The optimal TREC cutoff was established using ROC analysis, with validation across patients with SCID, 22q11.2 deletion syndrome (22q11.2DS), and syndromic forms of PID from an extended validation cohort of PID patients from the Dmitry Rogachev National Medical Research Center.

RESULTS

Receiver operating characteristic (ROC) analysis based on true-positive cases identified an optimal TREC cutoff of 150 copies/10 cells. Values between 150-200 copies/10 cells were found to identify high-risk newborns who require closer monitoring. This threshold was validated in an independent cohort, reducing missed SCID cases while improving the detection of 22q11.2 deletion syndrome and other syndromic primary immunodeficiencies (PIDs). Notably, elevated TREC levels in some SCID patients reflected "leaky" SCID phenotypes, which nonetheless required curative intervention. Additionally, syndromic PIDs and cases of transient idiopathic lymphopenia (TIL) were also more accurately identified, enabling timely clinical management.

CONCLUSION

These findings emphasize the need for broader evaluation of TREC cutoff values across diverse assay systems to improve the effectiveness, comparability, and global harmonization of NBS programs.

摘要

背景

严重联合免疫缺陷(SCID)的新生儿筛查(NBS)依靠测量T细胞受体切除环(TREC)进行早期诊断和干预。然而,各国和检测平台的TREC临界值存在显著差异,这给标准化和最佳筛查性能带来了挑战。本研究旨在优化俄罗斯一个大型NBS试点队列中202,908名新生儿的TREC临界值,主要侧重于提高SCID检测的敏感性。

方法

对一个NBS试点项目中的202,908名新生儿进行回顾性分析,评估TREC和KREC水平。将确诊的原发性免疫缺陷病(PID)诊断结果与一组66例假阳性病例的TREC测量值进行比较。使用ROC分析确定最佳TREC临界值,并在来自德米特里·罗加乔夫国家医学研究中心的PID患者扩展验证队列中的SCID患者、22q11.2缺失综合征(22q11.2DS)患者和综合征性PID患者中进行验证。

结果

基于真阳性病例的受试者操作特征(ROC)分析确定最佳TREC临界值为150拷贝/10⁵细胞。发现150 - 200拷贝/10⁵细胞之间的值可识别需要密切监测的高危新生儿。该阈值在一个独立队列中得到验证,减少了漏诊的SCID病例,同时提高了对22q11.2缺失综合征和其他综合征性原发性免疫缺陷病(PID)的检测。值得注意的是,一些SCID患者的TREC水平升高反映了“渗漏型”SCID表型,尽管如此仍需要进行治愈性干预。此外,综合征性PID和短暂性特发性淋巴细胞减少症(TIL)病例也能更准确地识别,从而实现及时的临床管理。

结论

这些发现强调需要在不同检测系统中对TREC临界值进行更广泛的评估,以提高NBS项目的有效性、可比性和全球协调性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验